Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 1886 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Werum IT Solutions AG. (5/2/16). "Press Release: Pharma Tech Firms Werum IT Solutions and Zenith Technologies Announce Global MES Partnership". Lüneburg. 2016-05-02
NMI TT Pharmaservices. (5/2/16). "Press Release: Sentinel Oncology and NMI TT Pharmaservices Awarded Eurostars Grant for Development of a Novel Biomarker for Treatment of Fragile X Syndrome". Cambridge & Berlin. 2016-05-02
OBN (UK) Ltd.. (4/28/16). "Press Release: Elasmogen Winner of the Perfect Pitch at the 2016 BioTrinity Conference in London". London. 2016-04-28
Oxford BioMedica plc. (4/28/16). "Press Release: Preliminary Results for the Year Ended 31 December 2015". Oxford. 2016-04-28
Sygnis AG. (4/28/16). "Press Release: Sygnis Reports Financial Results for Fiscal Year 2015". Madrid & Heidelberg. 2016-04-28
Toximet Ltd.. (4/28/16). "Press Release: Bio-Check (UK) Acquire ToxiMet". 2016-04-28
UBS AG. (4/27/16). "Press Release: UBS Raises Record $471m for Oncology Impact Fund". Zurich & Basel. 2016-04-27
Adaptimmune Therapeutics plc. (4/27/16). "Press Release: Adaptimmune to Present at the Deutsche Bank Securities 41st Annual Health Care Conference". 2016-04-27
GlaxoSmithKline plc. (4/27/16). "Press Release: GSK Statement on Pneumococcal Vaccine Pricing". 2016-04-27
AstraZeneca plc. (4/26/16). "Press Release: AstraZeneca Enters into US Licensing Agreement with Ironwood Pharmaceuticals for Lesinurad". 2016-04-26
Evotec AG. (4/26/16). "Press Release: Evotec and Ex Scientia Announce Partnership to Discover Bispecific Small Molecule Immuno-oncology Therapeutics". Hamburg & Dundee. 2016-04-26
Zymeworks Inc.. (4/26/16). "Press Release: Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies". Vancouver. 2016-04-26
Oxford BioMedica plc. (4/26/16). "Press Release: Oxford BioMedica Announces Stuart Henderson Appointed as a Non-executive Director". London. 2016-04-26
Horizon Discovery Group plc. (4/26/16). "Press Release: Preliminary Results for the Year Ended 31 Dec 2015". Cambridge. 2016-04-26
Alizé Pharma S.A.S.. (4/26/16). "Press Release: Alizé Pharma Reports Positive Results from Its Phase II Clinical Trial of AZP-531 in Prader-Willi Syndrome". Lyon. 2016-04-26
AstraZeneca plc. (4/25/16). "Press Release: Bevespi Aerosphere Approved by the US FDA for Patients with COPD". 2016-04-25
AstraZeneca plc. (4/22/16). "Press Release: AstraZeneca Launches Integrated Genomics Approach to Transform Drug Discovery and Development". 2016-04-22
Adaptimmune Therapeutics plc. (4/22/16). "Press Release: Adaptimmune Appoints Leading Immunotherapy Experts from United States and Europe to Inaugural Scientific Advisory Board". Philadeliphia, PA & Oxford. 2016-04-22
Illumina, Inc.. (4/21/16). "Press Release: Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents". San Diego, CA. 2016-04-21
Specialized Medical Services-Oncology B.V. (SMS-Oncology). (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". 2016-04-21
F-Star Biotechnology Ltd.. (4/21/16). "Press Release: F-star to Present at Key Conferences in April and May 2016". Cambridge. 2016-04-21
iTeos Therapeutics S.A.. (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". Bilthoven. 2016-04-21
GlaxoSmithKline plc. (4/20/16). "Press Release: SBP and GSK Create New Center for Translational Neuroscience. Academic-Industry Alliance Seeks to Find and Validate New Targets for Drug Development". La Jolla, CA. 2016-04-20
Peak Scientific Instruments Ltd.. (4/20/16). "Press Release: Peak Scientific Wins Brace of Queen’s Awards for Enterprise". 2016-04-20
Precision Medicine Catapult. (4/19/16). "Press Release: Dr Belinda Quinn Appointed as Chief Executive Officer of the Precision Medicine Catapult". Cambridge. 2016-04-19
MorphoSys AG. (4/18/16). "Press Release: MorphoSys Licensing Partner GSK Starts Phase 2 Study with GSK3196165 (MOR103) in Hand Osteoarthritis". 2016-04-18
Oxford BioTherapeutics Ltd.. (4/18/16). "Press Release: Boehringer Ingelheim Exercises Option on Second Oncology Target Using Oxford BioTherapeutics’ OGAP System". Oxford. 2016-04-18
GlaxoSmithKline plc. (4/18/16). "Press Release: GSK Opens New State of the Art Respiratory Manufacturing Facility in Ware, UK". London. 2016-04-18
Adaptimmune Therapeutics plc. (4/18/16). "Press Release: Adaptimmune Announces New Vice President of Business Development, Wenyong Wang". Philadeliphia, PA & Oxford. 2016-04-18
Kymab Ltd.. (4/18/16). "Press Release: Kymab and Heptares Enter Strategic Collaboration to Discover, Develop and Commercialise Novel Antibody Therapeutics". Cambridge & London. 2016-04-18
Horizon Discovery Group plc. (4/15/16). "Press Release: Horizon Discovery Introduces High Throughput Platform for Immuno-Oncology Research". Cambridge. 2016-04-15
Agena Bioscience, Inc.. (4/14/16). "Press Release: Agena Bioscience and Horizon Discovery to Launch iPLEX Reference Standards for the MassARRAY System". San Diego, CA & Cambridge. 2016-04-14
AstraZeneca plc. (4/14/16). "Press Release: AstraZeneca Showcases Breadth of Oncology Portfolio at AACR 2016 Annual Meeting". 2016-04-14
Kymab Ltd.. (4/14/16). "Press Release: Kymab Appoints Leaders in Immuno-Oncology, Infectious Disease and Blood Disorders". Cambridge. 2016-04-14
Apollo Therapeutics Fund. (4/14/16). "Press Release: Dr Richard Butt Appointed CEO". Stevenage. 2016-04-14
Redx Pharma plc. (4/14/16). "Press Release: Redx Pharma plc Set for New HQ at Alderley Park". 2016-04-14
Redx Pharma plc. (4/14/16). "Press Release: Board and Senior Management Changes". 2016-04-14
Stevenage Bioscience Catalyst. (4/13/16). "Press Release: Sanofi Opens Partnering Office in Stevenage Bioscience Catalyst". Guildford. 2016-04-13
Cobra Biologics Ltd.. (4/13/16). "Press Release: Cobra and Lancaster Partnership Helps Unravel New Analytical Tool for DNA Topology". 2016-04-13
Forbion Capital Partners. (4/12/16). "Press Release: Forbion Closes Third Life Sciences Fund, FCF III, Raising over USD200M". Naarden & Munich. 2016-04-12
Symphogen A/S. (4/12/16). "Press Release: Symphogen Initiates Anti-MET Clinical Program and Presents Pre-Clinical Anti-MET Data at Annual AACR Meeting April 18th in New Orleans". Copenhagen. 2016-04-12
iStar Medical S.A.. (4/12/16). "Press Release: iStar Medical Secures €10 Million Financing. Funding Supports Product Development and CE-marking Clinical Study for Breakthrough Glaucoma Implant". Wavre. 2016-04-12
Cosmo Pharmaceuticals S.A.. (4/7/16). "Press Release: Cosmo Board Approves Change of Registered Seat". Luxembourg. 2016-04-07
Edinburgh Molecular Imaging Ltd.. (4/7/16). "Press Release: Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration". Edinburgh & Paris. 2016-04-07
Analytik Jena AG. (4/7/16). "Press Release: Analytik Jena Launches a New Model for the PlasmaQuant® PQ 9000 Series of ICP-OES Instruments". Jena. 2016-04-07
Adaptimmune Therapeutics plc. (4/7/16). "Press Release: Adaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting AFP in Liver Cancer". Philadeliphia, PA & Oxford. 2016-04-07
BioSilta Ltd.. (4/6/16). "Press Release: BioSilta Ltd Acquires Worldwide Rights to CyDisCo Technology from University of Oulu to Produce Proteins with Multi-industry Applications". Cambridge. 2016-04-06
Allergan plc. (4/6/16). "Press Release: Allergan and Heptares Announce Global R&D and Commercialization Partnership for Novel Treatments in Alzheimer's and Other Neurological Disorders". Dublin & London. 2016-04-06
Pfizer Inc.. (4/6/16). "Press Release: Pfizer Announces Termination of Proposed Combination with Allergan". New York, NY. 2016-04-06
Markes International Ltd.. (4/5/16). "Press Release: New Paper in Analytical Chemistry – Select-eV Unravels the Composition of Complex Motor Oils". 2016-04-05
Dotmatics Ltd.. (4/5/16). "Press Release: Dotmatics Partners with BioByte to Offer ClogP Across the Entire Dotmatics Platform". Bishops Stortford & Claremont, CA. 2016-04-05
Ipsen S.A.. (4/5/16). "Press Release: Dassault Systèmes and Ipsen Sign Collaborative Agreement to Develop Innovative Programs to Support Ipsen’s Drug Discovery". Paris. 2016-04-05
Proteome Sciences plc. (4/5/16). "Press Release: Deep Protein Profiling Key to Improving Cancer Treatment". Cobham. 2016-04-05
Oxford BioTherapeutics Ltd.. (4/4/16). "Press Release: Oxford BioTherapeutics Licenses Nerviano Medical Sciences’ Drug-Linker Technology to Develop Novel Antibody Drug Conjugates". Oxford & San Jose, CA & Nerviano. 2016-04-04
Human Longevity, Inc.. (4/4/16). "Press Release: Human Longevity, Inc. Completes $220 Million Series B Financing". San Diego, CA. 2016-04-04
Medigene AG. (4/4/16). "Press Release: Medigene Sells Partial Stake in Immunocore". Martinsried. 2016-04-04
Entasis Therapeutics Inc.. (4/4/16). "Press Release: Entasis Announces $50 Million Series B Financing Led by Clarus. Proceeds Will Advance Pipeline of Innovative Anti-infective Products". Waltham, MA. 2016-04-04
Fusion Antibodies Ltd.. (3/31/16). "Press Release: Fusion Antibodies and MAB Discovery Announce Project Collaboration". 2016-03-31
Bluebee. (3/31/16). "Press Release: Bluebee Announces €10 Million in Series A Financing". 2016-03-31
Adaptimmune Therapeutics plc. (3/30/16). "Press Release: U.S. Food and Drug Administration Grants Orphan Drug Designation to Adaptimmune’s T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma". Philadeliphia, PA & Oxford. 2016-03-30
CureVac AG. (3/30/16). "Press Release: CureVac Appoints Leading Experts to Its Scientific Advisory Board". Tübingen. 2016-03-30
Immunocore Ltd.. (3/30/16). "Press Release: Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma". Oxford. 2016-03-30
Sanofi S.A.. (3/29/16). "Press Release: Sanofi Appoints Dr. Yong-Jun Liu as Head of Research". Paris. 2016-03-29
Sanofi S.A.. (3/29/16). "Press Release: Sanofi Successfully Prices EUR 1.8 billion Bond Issue". Paris. 2016-03-29
Iterum Therapeutics Ltd.. (3/24/16). "Press Release: Iterum Therapeutics Licenses Global Rights to Novel Anti-Infective Compound. Secures $40 Million in Series A Funding". Dublin. 2016-03-24
ThromboGenics N.V.. (3/24/16). "Press Release: ThromboGenics To Present at Key Investor Meetings". Leuven. 2016-03-24
Redx Pharma plc. (3/24/16). "Press Release: Placing to Raise £10 Million". 2016-03-24
Topas Therapeutics GmbH. (3/22/16). "Press Release: Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders". Hamburg. 2016-03-22
Gimv. (3/22/16). "Press Release: Gimv Invests EUR 4 Million in Biopharma Company Topas Therapeutics Confirming Its Commitment to Life Sciences". Antwerp & Munich. 2016-03-22
Bridgepoint. (3/22/16). "Press Release: Bridgepoint Development Capital Acquires French Dental Equipment Manufacturer Acteon". 2016-03-22
bioMérieux S.A.. (3/22/16). "Press Release: bioMérieux and Copan Announce the First Commercial Success of their Collaboration for the Automation and Efficiency of Microbiology laboratories". Marcy l’Étoile. 2016-03-22
Metrion Biosciences Ltd.. (3/21/16). "Press Release: Metrion Biosciences and EU Partners Receive €2.2M Funding Award under Eurostars SME Programme". Cambridge. 2016-03-21
CureVac AG. (3/18/16). "Press Release: CureVac Strengthens Supervisory Board to Support Global Growth Opportunities and mRNA Product Expansion". Tübingen. 2016-03-18
Kymab Ltd.. (3/17/16). "Press Release: Kymab Appoints Dr David Chiswell as Chief Executive Officer". Cambridge. 2016-03-17
Agilent Technologies Inc.. (3/17/16). "Press Release: Agilent Technologies Receives Award for Outstanding Customer Service for Second Straight Year". Santa Clara, CA. 2016-03-17
GlaxoSmithKline plc. (3/16/16). "Press Release: GSK and Miltenyi Biotec Establish Cell and Gene Therapy Collaboration". 2016-03-16
Microsaic Systems plc. (3/16/16). "Press Release: Audited Financial Results for the Year Ended 31 December 2015". 2016-03-16
Atlantic Healthcare plc. (3/15/16). "Press Release: Atlantic Healthcare Closes $24 Million Financing with Founders of Salix Pharmaceuticals and Clinigen Group, and LDC". Cambridge. 2016-03-15
Cambridge Epigenetix Ltd.. (3/14/16). "Press Release: Cambridge Epigenetix Announces $21M Series B Financing and Appoints Dr Geoff Smith as CEO". Cambridge. 2016-03-14
Agilent Technologies Inc.. (3/14/16). "Press Release: Agilent Technologies Publishes Overview of Best Practices for Breast Cancer Diagnosis". Carpinteria, CA. 2016-03-14
Lipigon Pharmaceuticals AB. (3/14/16). "Press Release: Lipigon Pharmaceuticals and AstraZeneca Enter Drug Discovery Collaboration". 2016-03-14
PhoreMost Ltd.. (3/10/16). "Press Release: PhoreMost and The Wistar Institute Collaborate to Identify New Druggable Targets in Cancer, Immunotherapy and Aging". Cambridge. 2016-03-10
PsiOxus Therapeutics Ltd.. (3/10/16). "Press Release: PsiOxus Therapeutics Initiates Combination of Paclitaxel with Oncolytic Virus Enadenotucirev in Ovarian Cancer Study". Oxford. 2016-03-10
Edinburgh Molecular Imaging Ltd.. (3/9/16). "Press Release: Edinburgh Molecular Imaging Ltd Awarded Innovate UK Grant to Qualify the Role of EMI-137 in Colorectal Cancer Lesion Detection". 2016-03-09
Grifols S.A.. (3/8/16). "Press Release: Industrial Investments Plan 2016–2021 for the Bioscience Division. Grifols Will Invest USD 360M to Expand Its Manufacturing Capacities for Plasma-derived Therapies". Barcelona. 2016-03-08
Capella Bioscience Ltd.. (3/8/16). "Press Release: Capella Bioscience Completes Series A Financing of £11 million ($15.5 million) to Progress Antibody Pipeline". London. 2016-03-08
Definiens AG. (3/8/16). "Press Release: Definiens Launches Immunoprofiling Panel to Rapidly Screen Tissue Samples for Immune Responses". Munich. 2016-03-08
Oxford BioMedica plc. (3/7/16). "Press Release: Oxford BioMedica Announces Expanded Collaboration and Licence with Immune Design". Oxford. 2016-03-07
Autolus Ltd.. (3/3/16). "Press Release: Autolus Limited Secures £40 Million Funding – Woodford Investment Management and Perceptive Bioscience Complete Series B Financing". London. 2016-03-03
Autolus Ltd.. (3/3/16). "Press Release: Autolus Limited Appoints Chief Executive Officer – Dr. Christian Itin, Pioneer of T-cell Targeting Therapeutics, Takes the Helm of Europe’s Leading Engineered T-cell Developer". London. 2016-03-03
Scion Instruments. (3/3/16). "Press Release: Scion Instruments Launches Latest Release of CompassCDS Chromatography Data System". 2016-03-03
Horizon Discovery Group plc. (3/2/16). "Press Release: Horizon Discovery Group plc Enters Immuno-Oncology Therapeutic Development and Forms Joint Venture with Centauri Therapeutics Limited". Cambridge. 2016-03-02
C4X Discovery Holdings plc. (3/1/16). "Press Release: Acquisition of Genetic Analysis Company. Adorial Limited Augments C4X Discovery’s Drug Discovery Engine". 2016-03-01
Oxford Immunotec Global plc. (3/1/16). "Press Release: Oxford Immunotec Reports Fourth Quarter and Full Year 2015 Financial Results". Oxford & Marlborough, MA. 2016-03-01
ImaBiotech S.A.S.. (3/16). "Press Release: Imabiotech Obtain 6M€ for a New European Project in Partnership with Lille I University and Cubic Pharmaceuticals". 2016-03-01
Thermo Fisher Scientific Inc.. (3/1/16). "Press Release: Accurately Detect Volatile Organic Compounds in Manufactured Products. Fisher Chemical GC Headspace-grade Solvents Are Designed to Detect Residual Solvents for Ensuring Consumer Safety". Waltham, M 2016-03-01
Retina Implant AG. (2/29/16). "Press Release: Retina Implant AG Secures €26 Million Round of Private Funding". Reutlingen. 2016-02-29
Definiens AG. (2/29/16). "Press Release: Definiens Appoints Michael Rasche Global Head of Sales, Expands Executive Team". Munich. 2016-02-29
Ziarco Pharma Ltd.. (2/29/16). "Press Release: Ziarco Appoints Dr. Arvind Hundal as Chief Business Officer". Discovery Park, Sandwich. 2016-02-29
Blue Scientific Ltd.. (2/25/16). "Press Release: Accurion Selects Blue Scientific as UK and Nordic Agent". 2016-02-25
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page



Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px